General Provisions  


NAC 639.661. Definitions.
NAC 639.6611. “Active ingredient” defined.
NAC 639.6613. “Ante-area” defined.
NAC 639.6615. “Barrier isolator cabinet” defined.
NAC 639.6617. “Beyond-use date” defined.
NAC 639.6619. “Buffer area” defined.
NAC 639.6621. “Chart order” defined.
NAC 639.6623. “Component” defined.
NAC 639.6625. “Compound” and “compounding” defined.
NAC 639.6627. “Compounding aseptic containment isolator” defined.
NAC 639.6629. “Compounding aseptic isolator” defined.
NAC 639.663. “Cytotoxic” defined.
NAC 639.6631. “Drug product” defined.
NAC 639.6633. “Gloved fingertip sampling” defined.
NAC 639.6635. “Hazardous drug” defined.
NAC 639.6637. “High-risk sterile compounded drug product” defined.
NAC 639.6639. “Immediate-use sterile compounded drug product” defined.
NAC 639.6641. “ISO Class 5” defined.
NAC 639.6643. “ISO Class 7” defined.
NAC 639.6645. “ISO Class 8” defined.
NAC 639.6647. “Low-risk sterile compounded drug product” defined.
NAC 639.6649. “Media fill test” defined.
NAC 639.665. “Medical facility” defined.
NAC 639.6655. “Medium-risk sterile compounded drug product” defined.
NAC 639.6665. “Nonsterile compounded drug product” defined.
NAC 639.667. “Nursing personnel” defined.
NAC 639.6673. “Parenteral nutrition” defined.
NAC 639.6677. “Sterile compounded drug product” defined.
NAC 639.670. Adoption of certain publications by reference; revision of publication after adoption.